A poster by the ABRF DNA Sequencing Research Group (DSRG), presented at AGBT 2023.
The HIVE stabilized all cells in the renal cell carcinoma sample, but cryopreservation damaged the sample.
The HIVE yielded quality scRNAseq data through 20 weeks’ storage
The HIVE locks the single-cell molecular signature of samples as if they were fresh, furthering biopharma research.
Convalescent Individuals With Previous Severe COVID-19 Have Increased Abundance of Interferon-Expressing Neutrophils in Circulation
Accurate cell counting and loading of HIVEs saves sequencing dollars
Large cells or debris can clog other technologies but are washed away from the HIVE, allowing for whole-cell scRNAseq from hepatocytes.
Bone marrow cells captured with the HIVE scRNAseq device maintain their biological profile, unlike cryopreserved cells.
Our Director of Applications and Collaborations, Irene Whitney, Ph.D, presents new data generated from the HIVE scRNAseq Solution.
